Fig. 1 · Structure
Documents & Downloads
S07-2001
AKR1C3 Inhibitor
S07-2001 is a selective inhibitor of aldo-keto reductase 1C3 (AKR1C3), exhibiting an IC50 value of 2.08 μM. This compound enhances the efficacy of Doxorubicin in cancer cells, making it a promising candidate for overcoming chemoresistance. Its mechanism of action and potent bioactivity support its potential applications in cancer therapeutics research.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1197904-57-6 |
| Applications | AKR1C3 Inhibitor |
| Formula | C15H17N3O4S |
| Molecular Weight | 335.38 |
| SMILES | O=C(C1=CC(C(C)=O)=CN1)NCC2=CC=C(CS(=O)(N)=O)C=C2 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.